KEGG   DRUG: Lenzilumab
Entry
D11236                      Drug                                   
Name
Lenzilumab (USAN/INN)
Formula
C6474H10024N1748O2010S42
Exact mass
145760.4169
Mol weight
145850.18
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYSFT NYYIHWVRQA PGQRLEWMGW INAGNGNTKY
SQKFQGRVTI TRDTSASTAY MELSSLRSED TAVYYCVRRQ RFPYYFDYWG QGTLVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
EIVLTQSPAT LSVSPGERAT LSCRASQSVG TNVAWYQQKP GQAPRVLIYS TSSRATGITD
RFSGSGSGTD FTLTISRLEP EDFAVYYCQQ FNKSPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplastic, Anti-GM-CSF antibody
  Type
Monoclonal antibody
Target
CSF2 [HSA:1437] [KO:K05427]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   CSF and other factors
    CSF2
     D11236  Lenzilumab (USAN/INN)
Other DBs
CAS: 1229575-09-0
PubChem: 384585214
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system